DR Izanne Roos
Senior Research Fellow in Multiple Sclerosis
Department of Medicine
163 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
DOI: 10.1136/jnnp-2026-3390592026
Journal article
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
DOI: 10.1093/brain/awag2522026
Journal article
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study
DOI: 10.1007/s40263-026-01287-82026
Journal article
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability
DOI: 10.1212/WNL.00000000002180562026
Research grants (ARC, NHMRC, MRFF)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2025
Research grants (ARC, NHMRC, MRFF)
Evidence Based Use of High-Efficacy Therapies in Multiple Sclerosis
2022
Research Grant
Personalised Therapy to Prevent Disability in Aggressive Multiple Sclerosis
RECENT SCHOLARLY WORKS
2026
Journal article
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
DOI: 10.1093/brain/awag0472026
Journal article
Predicting disease progression in multiple sclerosis with clinically accessible information and technology
DOI: 10.1007/s00415-026-13802-42026
Journal article
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder
DOI: 10.1212/WNL.00000000002147072026
Journal article
Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis
DOI: 10.1177/135245852614218162026
Journal article
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis
DOI: 10.1093/brain/awaf2862026
Journal article
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
DOI: 10.1007/s00415-026-13632-4
RECENT PROJECTS
2026
Research grants (other domestic)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2026
Research grants (other domestic)
Do Anti-Cd20 Therapies Benefit Non-Active Progressive MS? A Causal Inference Analysis Using Observational Data